SEC Form 4 · accession 0001179110-18-011086
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Aug 30, 2018 | S | 1,055 | $190.05 | D | 7,359 | D | |
| Ordinary Shares, par value $0.0001F1 | Sep 4, 2018 | G | 263 | $0.00 | D | 7,096 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.